i-Base home
Search Menu
  • Home
  • HTB
  • 2024
  • October

October 2024

Contents

Special reports

  • HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
  • Major update of UK PrEP guidelines online for public consultation

Conference reports

  • HIVR4P 2024: Introduction
  • Urgency of planning broad vaccine-like access to lenacapavir PrEP globally
  • Impact on CD4 counts of once-monthly islatravir in PrEP studies: early macaque results with MK-8527 follow-on compound
  • Lenacapavir PrEP in cisgender gay men, trans and gender-diverse people: results of the PURPOSE 2 study
  • HIVR4P 2024: Context of PrEP in Latin America

Treatment access

  • Helsinki Declaration: 2024 edition upholds ethical access to treatment
  • Gilead announces plans to support generic lenacapavir for low-income countries

mpox

  • Confirmed mpox clade 1b case in Germany: risk remains low for EU/EEA
  • Lack of tecovirimat activity against mpox clade 1
  • Efficacy of MVA-BN vaccine: systematic review
  • Mpox outbreak in Australia: half of cases had previously received a vaccine
  • WHO situation report on mpox

Coinfections and complications

  • Kidney transplants from HIV positive donors to HIV recipients

Treatment advocacy

  • US NIAID updates HIV guide to person-centred language

On the web

  • Long COVID essentials: link to online resources
  • HTB RSS

Early access

  • Vaccination effectively limits mpox progression: lower efficacy in people living with HIV 27 May 2025
  • US update guidelines for statin use in people living with HIV 26 May 2025
  • HIV activists in the US call for action and Zachie Achmet brings South African perspective 26 May 2025
  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook